AmerisourceBergen Foundation grant funds substance abuse symposium
AmerisourceBergen’s charitable arm and Thomas Jefferson University are teaming to fight opioid abuse and misuse in the Philadelphia area. The AmerisourceBergen Foundation has awarded the university a $50,000 grant to sponsor its second annual Substance Use Disorders Symposium.
The symposium, set to take place on May 29 at the university’s Center City campus, will bring lawmakers, community representatives and lawmakers to talk about a coordinated approach to curb the opioid crisis across the city. Speakers will focus on such topics as medication-assisted treatment, pain management for patients in recovery and management of opioid overdose, as well as patient perspectives on addiction and recovery.
“We are delighted that the AmerisourceBergen Foundation has offered to support Jefferson’s opioid crisis educational conference, which will shed light on this devastating public health emergency,” chair of the Thomas Jefferson University Dept. of Emergency Medicine Theodore Christopher said. “In addition to prescribing less opioid medication to all patients, physicians need to learn about the processes and logistics around treating opioid-addicted patients, and referring them to appropriate facilities and providers in the city.”
This partnership is the latest of the AmerisourceBergen Foundation’s collaboration with the university to help meet community needs. It donated $250,000 for a pharmacy at Project HOME’s Stephen Klein Wellness Center in North Philadelphia, and in 2017, the foundation gave $50,000 to the university’s Sidney Kimmel Cancer Center to support its cancer support and welcome center.
“As leaders in this region and across the nation organize efforts to combat opioid abuse, we — at AmerisourceBergen — aim to provide them with the resources needed to prevent misuse and drive sustained change,” said Gina Clark, AmerisourceBergen Foundation president and executive vice president and chief communications and administration officer at AmerisourceBergen. “At AmerisourceBergen, we are united in our responsibility to create healthier futures. Through our work with Thomas Jefferson University, we hope to convene leaders within the healthcare industry and community to identify best practices and develop action plans to combat opioid abuse.”
For more information about the symposium, click here.
PerceptiMed’s ScripClip processes 1M scripts
Pharmacy technology company PerceptiMed has seen its will call technology ScripClip pass a big milestone. The Mountain View, Calif.-based company said Thursday that the technology, launched last year, has safely processed more than 1 million prescriptions as it expands its reach through the United States, Canada and Puerto Rico.
“Our ScripClip product provides pharmacies with a customer-facing solution for faster prescription pickups combined with improved safety,” PerceptiMed CEO Bob Curry said. “It’s the rare pharmacy automation product that pharmacy customers can actually see in operation and tells customers that their pharmacy cares about both service and their safety as a patient. We are proud of reaching this milestone in having fulfilled our millionth prescription.”
Pharmacies using the ScripClip system have avoided roughly 1,000 safety incidents, according to a pharmacy saety study, PerceptiMed said. Among the issues the system looks to eliminate are patients receiving the wrong prescriptions or incomplete prescriptions, as well as adverse reactions and HIPAA violations, all of which the company said can be costly and time-consuming.
“ScripClip pharmacies achieve quick ROIs in only six to twelve months of use,” PerceptiMed chief business officer Frank Maione said. “The financial savings are a combination of better inventory management through easy to perform return-to-stock protocols, higher customer retention rates and will call labor savings.”
CVS Health earns NCQA utilization management accreditation
CVS Health’s pharmacy benefits manager CVS Caremark has been accredited by the National Committee for Quality Assurance in utilization management.
The NCQA utilization management accreditation is earned through a quality assessment program focused on protecting consumers and improving customer service. Its standards recognize applicants with open access networks that can use customized structures to meet purchaser needs while improving service quality.
“At CVS Caremark, we are pleased to maintain our NCQA Utilization Management Accreditation, which we’ve held continuously for the past several years,” CVS Health COO Jonathan Roberts said. “This accreditation affirms that our program provides high quality service and care to our PBM clients and their members as we strive to ensure that members access clinically appropriate and cost effective therapies to help improve health outcomes and lower costs.”
CVS Caremark’s utilization management program is designed to encourage appropriate and effective medication use. The company said that it identifies optimal drug use and promotes drug benefit plans that are cost-effective by using evidence-based drug information, as well as published guidelines, consensus statements and standards of medical practice.
“Achieving utilization management accreditation from NCQA demonstrates that CVS Health has the systems, process and personnel in place to conduct utilization management in accordance with the strictest quality standards,” NCQA president Margaret O’Kane said.
The accreditation process involves an evaluation that is conducted by a team of physicians and managed care experts, whose findings are then analyzed by an independent oversight committee of physicians, which then assigns an accreditation status based on an organization’s performance against standards.